An undergoing study, PREDICT, was launched to explore a variant of the TNFSF13B gene, commonly known as BAFF-var, that is linked to an elevated risk of developing immune-mediated diseases, including SLE and rheumatoid arthritis (RA). This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.